XML 74 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Balance Sheet Account Details - Contingent Liabilities (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Contingent Liability [Roll Forward]    
Commercial rights at beginning of period $ 49,133 $ 8,942
Additional Contingent Liabilities   41,800
Payments (1,820) (2,325)
Fair Value Adjustment (36,242) 963
Repurchases 0 (247)
Commercial rights at end of period 11,071 49,133
Cydex    
Contingent Liability [Roll Forward]    
Commercial rights at beginning of period 508 348
Additional Contingent Liabilities   0
Payments (50) 0
Fair Value Adjustment (108) 160
Repurchases 0 0
Commercial rights at end of period 350 508
Metabasis    
Contingent Liability [Roll Forward]    
Commercial rights at beginning of period 3,821 5,935
Additional Contingent Liabilities   0
Payments 0 0
Fair Value Adjustment (464) (1,867)
Repurchases 0 (247)
Commercial rights at end of period 3,357 3,821
Crystal    
Contingent Liability [Roll Forward]    
Commercial rights at beginning of period 800 2,659
Additional Contingent Liabilities   0
Payments 0 (1,800)
Fair Value Adjustment (800) (59)
Repurchases 0 0
Commercial rights at end of period 0 800
Icagen    
Contingent Liability [Roll Forward]    
Commercial rights at beginning of period 6,404 0
Additional Contingent Liabilities   4,800
Payments (1,050) (525)
Fair Value Adjustment 2,010 2,129
Repurchases 0 0
Commercial rights at end of period 7,364 6,404
Pfenex    
Contingent Liability [Roll Forward]    
Commercial rights at beginning of period 37,600 0
Additional Contingent Liabilities   37,000
Payments 0 0
Fair Value Adjustment (37,600) 600
Repurchases 0 0
Commercial rights at end of period 0 37,600
xCella    
Contingent Liability [Roll Forward]    
Commercial rights at beginning of period 0 0
Additional Contingent Liabilities   0
Payments (720) 0
Fair Value Adjustment 720 0
Repurchases 0 0
Commercial rights at end of period $ 0 $ 0